Elevance Health expects FY2026 GAAP EPS of at least $19.85
Elevance Health expects FY2026 GAAP EPS of at least $19.85 per share and reaffirmed adjusted EPS of at least $26.75 per share, signaling confidence in its operational performance.
*this image is generated using AI for illustrative purposes only.
Elevance Health expects its FY2026 GAAP earnings per share (EPS) to reach at least $19.85. The company also reaffirmed its adjusted EPS guidance of at least $26.75 per share for the fiscal year.
The guidance provides investors with a clear outlook on the company's profitability expectations for the upcoming fiscal year. The reaffirmation of adjusted EPS suggests confidence in the company's core operational performance.
Financial Guidance
The following table outlines the EPS guidance provided by Elevance Health for FY2026:
| Metric | Guidance |
|---|---|
| GAAP EPS | At least $19.85 |
| Adjusted EPS | At least $26.75 |
Elevance Health is listed on the NYSE under the ticker symbol ELV.
What strategic initiatives will Elevance Health prioritize to bridge the gap between GAAP and adjusted EPS?
How might changes in healthcare policy or regulatory environments impact the company's ability to meet these targets?
What are the anticipated trends in medical cost ratios that could influence profitability in FY2026?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
